C9orf172 Activators

Chemical activators of C9orf172 can facilitate its function through various cellular mechanisms. Forskolin, for example, is a potent activator of adenylate cyclase which increases intracellular cAMP levels, thereby activating protein kinase A (PKA). PKA is known to phosphorylate target proteins, and this post-translational modification can serve to activate C9orf172 by changing its conformation or by enabling its interaction with other cellular components. Similarly, Dibutyryl-cAMP, a cell-permeable analog of cAMP, directly engages PKA, following the same activation pathway towards C9orf172. Ionomycin, on the other hand, increases intracellular calcium levels. Elevated calcium can activate various calcium-dependent protein kinases, which can then target C9orf172 for phosphorylation and subsequent activation. Thapsigargin works to increase cytosolic calcium by inhibiting the Sarco/Endoplasmic Reticulum Ca2+ ATPase (SERCA), leading to a cascade that also promotes the activation of C9orf172 via calcium-dependent kinases.

In a similar vein, Phorbol 12-myristate 13-acetate (PMA) directly activates protein kinase C (PKC), which phosphorylates a broad range of targets, including potentially C9orf172, thus leading to its activation. Bryostatin 1, which is also a modulator of PKC, can indirectly facilitate the activation of C9orf172 through PKC-mediated phosphorylation pathways. Anisomycin activates the MAPK pathway involving kinases such as JNK and p38, which are implicated in the phosphorylation of various substrates, including what could be C9orf172. Additionally, oxidative stress agents like Hydrogen Peroxide are recognized as signaling molecules that can lead to the activation of C9orf172 through redox signaling pathways that involve the phosphorylation of proteins. Furthermore, S-Nitroso-N-acetylpenicillamine (SNAP), which releases nitric oxide, activates guanylate cyclase to increase cGMP levels, subsequently activating kinases that may target C9orf172 for activation. Inhibitors of protein phosphatases such as Okadaic Acid and Calyculin A maintain proteins in a phosphorylated state by preventing dephosphorylation, which can result in the continued activation of C9orf172. Lastly, Ouabain, by inhibiting the Na+/K+-ATPase, can raise intracellular calcium levels, again triggering pathways that phosphorylate and activate C9orf172. Each of these chemicals, through their distinctive modes of action, ensures the activation of C9orf172 by promoting its phosphorylation state, altering its conformation, or facilitating its interaction within the cellular milieu.